PharmaShots | Incisive News in 3 Shots

Subscribe Now

Alexion

Alexion’s Ultomiris (ravulizumab) Receives the Health Canada’s Approval for Generalized Myasthenia Gravis

Alexion’s Ultomiris (ravulizumab) Receives the Health Canada’s Approval for Generalized Myasthenia Gravis

January 18, 2023

Alexion to Acquire LogicBio Therapeutics for ~$68M

Alexion to Acquire LogicBio Therapeutics for ~$68M

October 3, 2022

PharmaShots Weekly Snapshots (August 30 - September 03, 2021)

PharmaShots Weekly Snapshots (August 30 - September 03, 2021)

September 3, 2021

PharmaShots Weekly Snapshots (August 23, 27, 2021)

PharmaShots Weekly Snapshots (August 23, 27, 2021)

August 27, 2021

Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis

Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis

August 23, 2021

PharmaShots Weekly Snapshots (July 26 - 30, 2021)

PharmaShots Weekly Snapshots (July 26 - 30, 2021)

July 30, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us